Burgess, Jeremy D.
Amerna, Danilyn
Norton, Emily S.
Parsons, Tammee M.
Perkerson, Ralph B. III
Faroqi, Ayman H.
Wszolek, Zbigniew K.
Guerrero Cazares, Hugo
Kanekiyo, Takahisa
Delenclos, Marion
McLean, Pamela J.
Funding for this research was provided by:
National Institute on Aging (F99AG068509-02)
Article History
Received: 20 April 2023
Accepted: 25 September 2023
First Online: 5 October 2023
Declarations
:
: Induced pluripotent stem cells utilized in this study were collected with informed consent under the project entitled “Parkinson’s Disease iPS Cell Line Research Consortium”, approved by the Mayo Clinic Institutional Review Board (Approval number: 09-003803; Initial approval 10/08/2009; latest renewal 5/22/2022). The studies described adhere to the Helsinki declaration.
: Not applicable.
: The authors declare that they have no competing interests.